AN INSIGHT ON MEDICINAL ATTRIBUTES OF PHTHALAZINE SCAFFOLD, WITH A FOCUS ON THEIR ANTICANCER PROPERTIES AS VEGFR-2 INHIBITORS
Al-Azhar Journal of Pharmaceutical Sciences · 01.03.2024 · 69 (1) · 25-37
DOI: 10.21608/ajps.2024.360355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Azhar Journal of Pharmaceutical Sciences, online erschienen am 01.03.2024. Verfasst von Mohammed A Dahab und 3 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
The antitumor properties of synthetic heterocyclic compounds are among the most powerful properties that can be made use in medicinal chemistry. More specifically, their significant cytotoxic effects against many types of human tumor cells, as well as their roles as various kinase inhibitors. In recent years, Phthalazine derivatives, have frequently attracted the interest of medicinal chemistry researchers due to their promising anticancer properties. The present study is a review of the latest advances in Phthalazine derivative-related research, with a focus on their anticancer activities as VEGFR-2 inhibitors.
Zitieren
APA
Dahab, M. A., Bayoumi, H. B., Khedr, F., & Ibrahim, M. K. (2024). AN INSIGHT ON MEDICINAL ATTRIBUTES OF PHTHALAZINE SCAFFOLD, WITH A FOCUS ON THEIR ANTICANCER PROPERTIES AS VEGFR-2 INHIBITORS. Al-Azhar Journal of Pharmaceutical Sciences, 69(1), 25-37. https://doi.org/10.21608/ajps.2024.360355
Vancouver
Dahab MA, Bayoumi HB, Khedr F, Ibrahim MK. AN INSIGHT ON MEDICINAL ATTRIBUTES OF PHTHALAZINE SCAFFOLD, WITH A FOCUS ON THEIR ANTICANCER PROPERTIES AS VEGFR-2 INHIBITORS. Al-Azhar Journal of Pharmaceutical Sciences. 2024;69(1):25-37. doi:10.21608/ajps.2024.360355
BibTeX
@article{Dahab2024,
author = {Dahab, Mohammed A and Bayoumi, Hatem B and Khedr, Fathalla and Ibrahim, Mohamed K},
title = {AN INSIGHT ON MEDICINAL ATTRIBUTES OF PHTHALAZINE SCAFFOLD, WITH A FOCUS ON THEIR ANTICANCER PROPERTIES AS VEGFR-2 INHIBITORS},
journal = {Al-Azhar Journal of Pharmaceutical Sciences},
year = {2024},
volume = {69},
number = {1},
pages = {25--37},
doi = {10.21608/ajps.2024.360355}
}
EUVIMED